Società NeuroOne Medical Technologies Corporation Other OTC
Azioni
NMTC
US64130M1009
Attrezzatura medica
Attività
Vendite per attività
USD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Strip/Grid Products, Stereoelectrocencephalography Products and Electrode Cable Assembly Products
57,3
%
| 0 | 8,1 % | 2 | 57,3 % | +1.040,65% |
Collaborations
42,7
%
| 2 | 91,9 % | 1 | 42,7 % | -25,33% |
Vendite per regione
USD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 2 | 100,0 % | 3 | 100,0 % | +60,73% |
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Mark Christanson
FOU | Founder | 56 | 20/08/09 |
David Rosa
CEO | Chief Executive Officer | 59 | 20/07/17 |
Ronald McClurg
DFI | Director of Finance/CFO | 65 | 01/01/21 |
Chief Operating Officer | 53 | 10/11 | |
Steven Mertens
CTO | Chief Tech/Sci/R&D Officer | 61 | 15/04/19 |
Chad Wilhelmy
LAW | General Counsel | - | 18/01/22 |
Hijaz Haris
SAM | Sales & Marketing | - | 27/04/21 |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Paul Buckman
CHM | Chairman | 68 | 04/08/17 |
Director/Board Member | 62 | 04/08/17 | |
Edward Andrle
BRD | Director/Board Member | 66 | 18/02/20 |
David Rosa
CEO | Chief Executive Officer | 59 | 20/07/17 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 27 515 921 | 24 385 250 ( 88,62 %) | 0 | 88,62 % |
Coordinate società
![Indirizzo NeuroOne Medical Technologies Corporation(NMTC)](https://cdn.zonebourse.com/static/address/36764942.png)
Settore
Vendite per attività
Variaz. 1 gen. | Capi. | |
---|---|---|
-27,91% | 16,33 Mrd | |
-56,07% | 2,17 Mrd | |
+19,09% | 1,88 Mrd | |
-12,63% | 1,45 Mrd | |
+29,99% | 1,32 Mrd | |
+8,32% | 853 Mln | |
-30,60% | 799 Mln | |
-36,50% | 726 Mln | |
+29,48% | 622 Mln |